ADMA Biologics Inc (ADMA)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Adam S. Grossman
Employees:
530
C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ 07446
(201) 478-5552

ADMA Biologics, Inc. engages in developing, manufacturing, and marketing specialty plasma-derived biologics. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI) and ASCENIV. Nabi-HB for the. treatment of acute exposure to blood containing Hepatitis B surface antigen.

Data derived from most recent annual or quarterly report
Market Cap 786.846 Million Shares Outstanding222.273 Million Avg 30-day Volume 1.713 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-0.03
Price to Revenue3.9484 Debt to Equity1.0257 EBITDA-6.714 Million
Price to Book Value5.5989 Operating Margin-8.0062 Enterprise Value909.723 Million
Current Ratio6.346 EPS Growth0.525 Quick Ratio2.366
1 Yr BETA 1.4461 52-week High/Low 4.65 / 2.24 Profit Margin-19.3605
Operating Cash Flow Growth51.6516 Free Cash Flow to Firm (FCFF) TTM -33.779 Million Free Cash Flow to Equity (FCFE) TTM-21.205 Million
Altman Z-Score1.7337
View SEC Filings from ADMA instead.

View recent insider trading info

ADMA Biologics Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding ADMA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ADMA

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-08-30 by GROSSMAN JERROLD B
  • 4: filed on 2023-08-24 by KWON YOUNG
  • 4: filed on 2023-08-23 by FONG BRYANT
  • 4: filed on 2023-08-18 by GROSSMAN ADAM S
  • 4: filed on 2023-08-17 by GROSSMAN ADAM S
  • 4: filed on 2023-08-17 by LENZ BRIAN
  • 4: filed on 2023-07-05 by LENZ BRIAN
  • 4: filed on 2023-07-05 by GROSSMAN ADAM S
  • 4: filed on 2022-12-09 by LENZ BRIAN
  • 4: filed on 2022-12-09 by GROSSMAN ADAM S

    • Events (8k)

  • 8-K: filed on 2023-08-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-07-19:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-06-06:
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-22:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-02:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 3.02: Unregistered Sales of Equity Securities
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-23:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-10:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-02-08:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-17:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

  • 144: filed on 2023-08-14:
  • 144: filed on 2023-08-14:
  • 144/A: filed on 2023-08-18:
  • 144: filed on 2023-08-22:

    • Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    155 Thousand total shares from 2 transactions

    Open Market Sells (S)

    2.6 Million total shares from 6 transactions

    Exercise Derivative Conversion (M)

    2.9 Million total shares from 12 transactions

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    GROSSMAN JERROLD B

    • Director
    		 535,972 2023-08-30 2

    KWON YOUNG

    • Director
    		 277,401 2023-08-24 2

    FONG BRYANT

    • Director
    		 59,901 2023-08-22 2

    GROSSMAN ADAM S PRESIDENT AND CEO

    • Officer
    • Director
    		 3,997,468 2023-08-18 7

    LENZ BRIAN EVP, CFO

    • Officer
    		 782,013 2023-08-15 6

    DEMSKI MARTHA J

    • Director
    		 56,601 2023-03-06 1

    ELMS STEVE

    • Director
    		 3,668,072 2023-03-06 1

    GUIHEEN LAWRENCE P.

    • Director
    		 130,901 2023-03-06 1

    PERCEPTIVE ADVISORS LLC

    PERCEPTIVE LIFE SCIENCES MASTER FUND LTD

    EDELMAN JOSEPH

    • 10% Owner
    		 13,262,375 2021-09-28 0

    MOND JAMES EVP, CSO AND CMO

    • Officer
    		 276,535 2021-02-25 0

    GOLDSTEIN DOV A MD

    • Director
    		 7,500 2020-02-28 0

    RICHMAN ERIC I

    • Director
    		 44,030 2020-02-28 0

    BIOTEST DIVESTITURE TRUST

    • 10% Owner
    		 4,295,580 2019-06-06 0

    BIOTEST AG

    BIOTEST PHARMACEUTICALS CORP

    • 10% Owner
    		 10,109,534 2018-05-14 0

    EHMER BERNHARD

    • Director
    		 0 2017-06-06 0

    AISLING CAPITAL II LP

    AISLING CAPITAL PARTNERS LLC

    AISLING CAPITAL PARTNERS, LP

    SCHIFF ANDREW N

    PURCELL DENNIS J

    ELMS STEVE

    • 10% Owner
    		 3,620,143 2013-10-22 0

    WARSHAW KIRK M CFO, SECRETARY

    • Officer
    		 100,000 2006-09-08 0

    R & R INVESTMENTS VI LLC

    • 10% Owner
    		 2,000,000 2006-09-08 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    GROSSMAN JERROLD B - Director

    		2023-08-30 16:58:14 -0400 2023-08-30 P 130,000 $3.71 a 443,265 direct 1.039 -0.2597 3.8961 4 -0.2597 6

    KWON YOUNG - Director

    		2023-08-24 19:53:31 -0400 2023-08-24 P 25,000 $3.90 a 277,401 direct -4.0506 -1.519 0.0 1 -7.3418 4

    FONG BRYANT - Director see footnote

    		2023-08-23 20:30:22 -0400 2023-08-22 S 1,433,304 $3.87 d 0 indirect 2.0672 -0.5168 2.0672 2 -5.4264 5

    GROSSMAN ADAM S - Director - Officer PRESIDENT AND CEO

    		2023-08-18 21:46:47 -0400 2023-08-18 S 250,000 $4.15 d 2,273,085 direct -4.2079 -6.1881 0.0 1 -6.1881 6

    GROSSMAN ADAM S - Director - Officer PRESIDENT AND CEO

    		2023-08-17 21:30:51 -0400 2023-08-16 S 3 $4.39 d 2,523,085 direct -1.4634 -3.6585 0.0 1 -5.6098 3

    LENZ BRIAN - Officer EVP, CFO

    		2023-08-17 21:30:44 -0400 2023-08-16 S 178,184 $4.45 d 782,013 direct -1.4634 -3.6585 0.0 1 -5.6098 3

    GROSSMAN ADAM S - Director - Officer PRESIDENT AND CEO

    		2023-08-17 21:30:51 -0400 2023-08-15 M 277,131 $2.35 d 181,569 direct

    GROSSMAN ADAM S - Director - Officer PRESIDENT AND CEO

    		2023-08-17 21:30:51 -0400 2023-08-15 M 212,500 $1.67 d 387,500 direct

    GROSSMAN ADAM S - Director - Officer PRESIDENT AND CEO

    		2023-08-17 21:30:51 -0400 2023-08-15 M 277,604 $2.92 a 3,290,320 direct -1.4634 -3.6585 0.0 1 -5.6098 3

    GROSSMAN ADAM S - Director - Officer PRESIDENT AND CEO

    		2023-08-17 21:30:51 -0400 2023-08-15 M 277,604 $2.92 d 47,396 direct

    GROSSMAN ADAM S - Director - Officer PRESIDENT AND CEO

    		2023-08-17 21:30:51 -0400 2023-08-15 M 350,000 $3.71 a 4,040,320 direct -1.4634 -3.6585 0.0 1 -5.6098 3

    GROSSMAN ADAM S - Director - Officer PRESIDENT AND CEO

    		2023-08-17 21:30:51 -0400 2023-08-15 M 350,000 $3.71 d 0 direct

    GROSSMAN ADAM S - Director - Officer PRESIDENT AND CEO

    		2023-08-17 21:30:51 -0400 2023-08-15 M 400,000 $3.22 a 3,690,320 direct -1.4634 -3.6585 0.0 1 -5.6098 3

    GROSSMAN ADAM S - Director - Officer PRESIDENT AND CEO

    		2023-08-17 21:30:51 -0400 2023-08-15 M 400,000 $3.22 d 0 direct

    GROSSMAN ADAM S - Director - Officer PRESIDENT AND CEO

    		2023-08-17 21:30:51 -0400 2023-08-15 S 510,469 $4.54 d 4,113,075 direct -1.4634 -3.6585 0.0 1 -5.6098 3

    GROSSMAN ADAM S - Director - Officer PRESIDENT AND CEO

    		2023-08-17 21:30:51 -0400 2023-08-15 M 583,224 $3.66 a 4,623,544 direct -1.4634 -3.6585 0.0 1 -5.6098 3

    GROSSMAN ADAM S - Director - Officer PRESIDENT AND CEO

    		2023-08-17 21:30:51 -0400 2023-08-15 M 583,224 $3.66 d 0 direct

    GROSSMAN ADAM S - Director - Officer PRESIDENT AND CEO

    		2023-08-17 21:30:51 -0400 2023-08-15 F 1,589,987 $4.61 d 2,523,088 direct -1.4634 -3.6585 0.0 1 -5.6098 3

    GROSSMAN ADAM S - Director - Officer PRESIDENT AND CEO

    		2023-08-17 21:30:51 -0400 2023-08-15 M 277,131 $2.35 a 3,012,716 direct -1.4634 -3.6585 0.0 1 -5.6098 3

    LENZ BRIAN - Officer EVP, CFO

    		2023-08-17 21:30:44 -0400 2023-08-15 M 83,979 $2.35 a 963,387 direct -1.4634 -3.6585 0.0 1 -5.6098 3

    GROSSMAN ADAM S - Director - Officer PRESIDENT AND CEO

    		2023-08-17 21:30:51 -0400 2023-08-15 M 212,500 $1.67 a 2,735,585 direct -1.4634 -3.6585 0.0 1 -5.6098 3

    LENZ BRIAN - Officer EVP, CFO

    		2023-08-17 21:30:44 -0400 2023-08-15 F 631,078 $4.61 d 960,197 direct -1.4634 -3.6585 0.0 1 -5.6098 3

    LENZ BRIAN - Officer EVP, CFO

    		2023-08-17 21:30:44 -0400 2023-08-15 S 211,578 $4.60 d 782,013 direct -1.4634 -3.6585 0.0 1 -5.6098 3

    LENZ BRIAN - Officer EVP, CFO

    		2023-08-17 21:30:44 -0400 2023-08-15 M 200,000 $3.22 d 0 direct

    LENZ BRIAN - Officer EVP, CFO

    		2023-08-17 21:30:44 -0400 2023-08-15 M 200,000 $3.22 a 1,248,803 direct -1.4634 -3.6585 0.0 1 -5.6098 3

    LENZ BRIAN - Officer EVP, CFO

    		2023-08-17 21:30:44 -0400 2023-08-15 M 192,472 $3.66 d 0 direct

    LENZ BRIAN - Officer EVP, CFO

    		2023-08-17 21:30:44 -0400 2023-08-15 M 192,472 $3.66 a 1,591,275 direct -1.4634 -3.6585 0.0 1 -5.6098 3

    LENZ BRIAN - Officer EVP, CFO

    		2023-08-17 21:30:44 -0400 2023-08-15 M 150,000 $3.71 d 0 direct

    LENZ BRIAN - Officer EVP, CFO

    		2023-08-17 21:30:44 -0400 2023-08-15 M 150,000 $3.71 a 1,398,803 direct -1.4634 -3.6585 0.0 1 -5.6098 3

    LENZ BRIAN - Officer EVP, CFO

    		2023-08-17 21:30:44 -0400 2023-08-15 M 97,395 $1.67 d 177,605 direct

    LENZ BRIAN - Officer EVP, CFO

    		2023-08-17 21:30:44 -0400 2023-08-15 M 97,395 $1.67 a 879,408 direct -1.4634 -3.6585 0.0 1 -5.6098 3

    LENZ BRIAN - Officer EVP, CFO

    		2023-08-17 21:30:44 -0400 2023-08-15 M 85,416 $2.92 d 14,584 direct

    LENZ BRIAN - Officer EVP, CFO

    		2023-08-17 21:30:44 -0400 2023-08-15 M 85,416 $2.92 a 1,048,803 direct -1.4634 -3.6585 0.0 1 -5.6098 3

    LENZ BRIAN - Officer EVP, CFO

    		2023-08-17 21:30:44 -0400 2023-08-15 M 83,979 $2.35 d 55,021 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    ADMA BIOLOGICS INC ADMA 2023-09-29 22:15:03 UTC 4.3367 0.9833 7900000
    ADMA BIOLOGICS INC ADMA 2023-09-29 21:45:04 UTC 4.3367 0.9833 7900000
    ADMA BIOLOGICS INC ADMA 2023-09-29 21:15:03 UTC 4.3367 0.9833 7900000
    ADMA BIOLOGICS INC ADMA 2023-09-29 20:45:05 UTC 4.3367 0.9833 7900000
    ADMA BIOLOGICS INC ADMA 2023-09-29 20:15:04 UTC 4.4162 0.9038 7900000
    ADMA BIOLOGICS INC ADMA 2023-09-29 19:45:04 UTC 4.4162 0.9038 7900000
    ADMA BIOLOGICS INC ADMA 2023-09-29 19:15:03 UTC 0.0 0.0 7900000
    ADMA BIOLOGICS INC ADMA 2023-09-29 18:45:03 UTC 0.0 0.0 7900000
    ADMA BIOLOGICS INC ADMA 2023-09-29 18:15:03 UTC 0.0 0.0 7900000
    ADMA BIOLOGICS INC ADMA 2023-09-29 17:45:03 UTC 4.4603 0.8597 7900000
    ADMA BIOLOGICS INC ADMA 2023-09-29 17:15:04 UTC 4.4603 0.8597 7900000
    ADMA BIOLOGICS INC ADMA 2023-09-29 16:45:04 UTC 4.8302 0.4898 7900000
    ADMA BIOLOGICS INC ADMA 2023-09-29 16:15:03 UTC 4.8302 0.4898 7900000
    ADMA BIOLOGICS INC ADMA 2023-09-29 15:45:04 UTC 4.8302 0.4898 7900000
    ADMA BIOLOGICS INC ADMA 2023-09-29 15:15:04 UTC 4.8302 0.4898 7900000
    ADMA BIOLOGICS INC ADMA 2023-09-29 14:45:04 UTC 4.8302 0.4898 7900000
    ADMA BIOLOGICS INC ADMA 2023-09-29 14:15:04 UTC 4.8302 0.4898 7900000
    ADMA BIOLOGICS INC ADMA 2023-09-29 13:45:03 UTC 4.8302 0.4898 7900000
    ADMA BIOLOGICS INC ADMA 2023-09-29 13:15:04 UTC 4.8302 0.4898 7900000
    ADMA BIOLOGICS INC ADMA 2023-09-29 12:45:05 UTC 4.8302 0.4898 7900000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments